In a new scientific article, researchers at Uppsala University describe how, using a completely new method, they have synthesised an artificial enzyme that functions in the metabolism of living cells. These enzymes can utilize the cell’s own energy, and thereby enable hydrogen gas to be produced from solar energy.
Hydrogen gas has long been noted as a promising energy carrier, but its production is still dependent on fossil raw materials. Renewable hydrogen gas can be extracted from water, but as yet the systems for doing so have limitations.
In the new article, published in the journal Energy and Environmental Science, an interdisciplinary European research group led by Uppsala University scientists describe how artificial enzymes convert solar energy into hydrogen gas. This entirely new method has been developed at the University in the past few years. The technique is based on photosynthetic microorganisms with genetically inserted enzymes that are combined with synthetic compounds produced in the laboratory. Synthetic biology has been combined with synthetic chemistry to design and create custom artificial enzymes inside living organisms.
“We’ve now been able to use the method we developed to produce enzymes that use the cell’s own energy to produce hydrogen gas,” says Adam Wegelius, a PhD student at the Department of Chemistry – Ångström Laboratory, Uppsala University.
Senior Lecturer Gustav Berggren and Professor Peter Lindblad of the same department have been jointly leading the research.
“Evolution has already developed and refined a tool for capturing sunlight through photosynthesis. And by introducing our artificial enzyme into photosynthetic cyanobacteria we can directly benefit from this efficient process, thus producing hydrogen gas from solar energy. We’ve developed a completely new method, which allows us to go beyond the solutions offered by evolution and nature, in our development of artificial enzymes” Berggren says.
The Latest on: Artificial enzymes
via Google News
The Latest on: Artificial enzymes
- Artificial Saliva Market - Big Changes to Have Big Impact | GlaxoSmithKline, Fresenius Kabi, Perrigoon August 11, 2020 at 2:15 pm
Saliva plays an essential role in chewing, swallowing, digesting, and speaking. It also helps control bacteria in mouth, which helps avert infection and tooth decay. Natural saliva is made up of ...
- A magnetic-sensitive artificial catalyst can remotely control chemical reactions inside living cellson August 10, 2020 at 6:18 pm
The enzymes responsible for catalytic reactions in our body's biological reactions are difficult to use for diagnosis or treatment as they react only to certain molecules or have low stability.
- Nanocatalysts that remotely control chemical reactions inside living cellson August 10, 2020 at 8:18 am
The enzymes responsible for catalytic reactions in our body's biological reactions are difficult to use for diagnosis or treatment as they react only to certain molecules or have low stability. Many ...
- Nanocatalysts remotely control chemical reactions inside living cellson August 10, 2020 at 7:56 am
Researchers developed a remote magnetic-sensitive artificial catalyst, which shows high catalytic efficiency within living cells.
- The Robot Scientists Are Coming. But That's Not a Bad Thingon August 10, 2020 at 6:03 am
A small but growing crop of machines is learning to design and carry out its own experiments. How will this change the future of research?
- Codexis Adds Dr. Jennifer L. Aaker to its Board of Directorson August 6, 2020 at 4:17 am
Codexis Adds Dr. Jennifer L. Aaker to its Board of Directors Dr. Jennifer L. AakerREDWOOD CITY, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering ...
- Researchers develop first synthetic inhibitor of coagulation factor XIIon August 5, 2020 at 3:58 am
A new FXII inhibitor has been developed that efficiently blocked coagulation in a thrombosis model without increasing the risk of bleeding.
- Therapeutic Anticoagulant with No Bleeding Side Effects Reportedly Developedon August 4, 2020 at 1:03 pm
The mice without the enzyme had a reduced risk of thrombosis without having ... peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs” in Nature ...
- Researchers create artificial organelles to control cellular behavioron August 4, 2020 at 9:13 am
Biomedical engineers at Duke University have demonstrated a method for controlling the phase separation of an emerging class of proteins to create artificial membrane-less organelles within human ...
via Bing News